Anika Therapeutics Inc (ANIK) — Analysis Summary
Anika Therapeutics Inc (ANIK) has a market cap of $193.33M with year-over-year revenue growth of -5.9%. Net margin stands at -9.6%. The stock trades at a P/E ratio of -17.5.
Key Takeaways
- Revenue changed -5.9% year-over-year
- Net margin of -9.6%
- P/E ratio of -17.5
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, ANIK posted revenue growth of -5.9% and trades at a P/E of -17.5.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.